HEADER BIOSYNTHETIC PROTEIN 16-MAY-07 2PYX TITLE CRYSTAL STRUCTURE OF TRYPTOPHAN HALOGENASE (YP_750003.1) FROM TITLE 2 SHEWANELLA FRIGIDIMARINA NCIMB 400 AT 1.50 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPTOPHAN HALOGENASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SHEWANELLA FRIGIDIMARINA; SOURCE 3 ORGANISM_TAXID: 318167; SOURCE 4 STRAIN: NCIMB 400; SOURCE 5 GENE: YP_750003.1, SFRI_1312; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS YP_750003.1, TRYPTOPHAN HALOGENASE, STRUCTURAL GENOMICS, JOINT CENTER KEYWDS 2 FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 24-JUL-19 2PYX 1 REMARK LINK REVDAT 5 25-OCT-17 2PYX 1 REMARK REVDAT 4 18-OCT-17 2PYX 1 REMARK REVDAT 3 13-JUL-11 2PYX 1 VERSN REVDAT 2 24-FEB-09 2PYX 1 VERSN REVDAT 1 29-MAY-07 2PYX 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF TRYPTOPHAN HALOGENASE (YP_750003.1) JRNL TITL 2 FROM SHEWANELLA FRIGIDIMARINA NCIMB 400 AT 1.50 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 3 NUMBER OF REFLECTIONS : 184358 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.153 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 9258 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7145 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.33 REMARK 3 BIN R VALUE (WORKING SET) : 0.2000 REMARK 3 BIN FREE R VALUE SET COUNT : 394 REMARK 3 BIN FREE R VALUE : 0.2650 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 1587 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.45000 REMARK 3 B22 (A**2) : 0.33000 REMARK 3 B33 (A**2) : 0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.066 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.069 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.039 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.007 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8824 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 7769 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12091 ; 1.443 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): 18208 ; 0.833 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1161 ; 5.549 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 422 ;40.335 ;24.976 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1453 ;11.028 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;12.078 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1336 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10027 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1726 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1769 ; 0.216 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 8083 ; 0.178 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4427 ; 0.178 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 5006 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 1201 ; 0.154 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 19 ; 0.299 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 79 ; 0.275 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 48 ; 0.145 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5522 ; 1.709 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2175 ; 0.430 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8792 ; 2.530 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3724 ; 3.803 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3242 ; 5.659 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 3. CL, TARTRATE, AND PEG WERE MODELED BASED ON CRYSTALLIZATION REMARK 3 AND CRYOPROTECTION CONDITIONS. REMARK 4 REMARK 4 2PYX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042938. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97916, 0.97885 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 184436 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.775 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.9 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : 0.06400 REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 50.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.31300 REMARK 200 R SYM FOR SHELL (I) : 0.31300 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.2M NA TARTRATE, 20.0% PEG REMARK 280 3350, NO BUFFER PH 7.2, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 48.77250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.01800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.80650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.01800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.77250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.80650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1,2 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT REMARK 300 OF A MONOMER AS A SIGNIFICANT OLIGOMERIZATION STATE REMARK 300 IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 33 CE NZ REMARK 470 HIS A 38 CG ND1 CD2 CE1 NE2 REMARK 470 VAL A 52 CG1 CG2 REMARK 470 ILE A 55 CG1 CG2 CD1 REMARK 470 GLN A 119 CD OE1 NE2 REMARK 470 GLN A 204 CD OE1 NE2 REMARK 470 LYS A 231 CD CE NZ REMARK 470 ASN A 266 CG OD1 ND2 REMARK 470 LYS A 325 CG CD CE NZ REMARK 470 GLU A 327 CG CD OE1 OE2 REMARK 470 ARG A 329 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 331 CG CD1 CD2 REMARK 470 GLN A 449 CG CD OE1 NE2 REMARK 470 LYS A 524 CG CD CE NZ REMARK 470 LEU A 525 CG CD1 CD2 REMARK 470 ILE B 55 CG1 CG2 CD1 REMARK 470 GLN B 204 CG CD OE1 NE2 REMARK 470 LYS B 214 CD CE NZ REMARK 470 ASN B 266 CG OD1 ND2 REMARK 470 LYS B 325 CG CD CE NZ REMARK 470 ARG B 329 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 501 CD OE1 NE2 REMARK 470 LYS B 505 CD CE NZ REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 LYS B 524 CG CD CE NZ REMARK 470 LEU B 525 C O CB CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 84 O HOH A 1296 2.04 REMARK 500 OE1 GLN B 398 O HOH B 1318 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MSE A 351 SE MSE A 351 CE -0.473 REMARK 500 MSE A 438 SE MSE A 438 CE -0.531 REMARK 500 MSE B 351 SE MSE B 351 CE -0.532 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 161 -5.96 72.79 REMARK 500 GLN A 215 13.12 -140.49 REMARK 500 PHE A 251 -42.33 73.52 REMARK 500 ASP A 253 18.70 -143.49 REMARK 500 ASN A 344 -123.94 51.47 REMARK 500 PRO A 358 27.02 -78.22 REMARK 500 TYR B 161 -2.45 70.22 REMARK 500 PHE B 251 -43.96 73.86 REMARK 500 ASN B 344 -124.37 50.20 REMARK 500 PRO B 358 27.18 -78.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 526 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA A 527 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA A 528 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA B 526 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA B 527 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 529 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 528 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 374311 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE REMARK 999 TARGET SEQUENCE. DBREF 2PYX A 1 525 UNP Q085A0 Q085A0_SHEFN 1 525 DBREF 2PYX B 1 525 UNP Q085A0 Q085A0_SHEFN 1 525 SEQADV 2PYX GLY A 0 UNP Q085A0 LEADER SEQUENCE SEQADV 2PYX MSE A 1 UNP Q085A0 MET 1 MODIFIED RESIDUE SEQADV 2PYX MSE A 2 UNP Q085A0 MET 2 MODIFIED RESIDUE SEQADV 2PYX MSE A 65 UNP Q085A0 MET 65 MODIFIED RESIDUE SEQADV 2PYX MSE A 351 UNP Q085A0 MET 351 MODIFIED RESIDUE SEQADV 2PYX MSE A 383 UNP Q085A0 MET 383 MODIFIED RESIDUE SEQADV 2PYX MSE A 385 UNP Q085A0 MET 385 MODIFIED RESIDUE SEQADV 2PYX MSE A 438 UNP Q085A0 MET 438 MODIFIED RESIDUE SEQADV 2PYX MSE A 471 UNP Q085A0 MET 471 MODIFIED RESIDUE SEQADV 2PYX MSE A 485 UNP Q085A0 MET 485 MODIFIED RESIDUE SEQADV 2PYX GLY B 0 UNP Q085A0 LEADER SEQUENCE SEQADV 2PYX MSE B 1 UNP Q085A0 MET 1 MODIFIED RESIDUE SEQADV 2PYX MSE B 2 UNP Q085A0 MET 2 MODIFIED RESIDUE SEQADV 2PYX MSE B 65 UNP Q085A0 MET 65 MODIFIED RESIDUE SEQADV 2PYX MSE B 351 UNP Q085A0 MET 351 MODIFIED RESIDUE SEQADV 2PYX MSE B 383 UNP Q085A0 MET 383 MODIFIED RESIDUE SEQADV 2PYX MSE B 385 UNP Q085A0 MET 385 MODIFIED RESIDUE SEQADV 2PYX MSE B 438 UNP Q085A0 MET 438 MODIFIED RESIDUE SEQADV 2PYX MSE B 471 UNP Q085A0 MET 471 MODIFIED RESIDUE SEQADV 2PYX MSE B 485 UNP Q085A0 MET 485 MODIFIED RESIDUE SEQRES 1 A 526 GLY MSE MSE GLN LYS PRO ILE THR GLU ILE ILE ILE VAL SEQRES 2 A 526 GLY GLY GLY THR ALA GLY TRP ILE THR ALA GLY LEU LEU SEQRES 3 A 526 ALA ALA GLU HIS ASN VAL ASP LYS GLY VAL LEU ALA HIS SEQRES 4 A 526 SER PRO LYS LEU ASN ILE THR LEU ILE GLU SER PRO ASP SEQRES 5 A 526 VAL ALA THR ILE GLY VAL GLY GLU GLY THR TRP PRO SER SEQRES 6 A 526 MSE ARG SER THR LEU SER LYS ILE GLY ILE ASP GLU ASN SEQRES 7 A 526 ASP PHE ILE ARG GLN CYS ASP ALA SER PHE LYS GLN GLY SEQRES 8 A 526 SER ARG PHE ILE ASN TRP CYS LYS ASP PRO GLN SER ASN SEQRES 9 A 526 VAL ALA ASP SER TYR LEU HIS PRO PHE SER LEU PRO HIS SEQRES 10 A 526 GLY HIS GLN GLU LEU ASP LEU CYS PRO TYR TRP LEU PRO SEQRES 11 A 526 HIS ALA GLU GLN VAL SER PHE ALA GLU ALA VAL CYS SER SEQRES 12 A 526 GLN GLN VAL LEU THR GLN LEU GLY LEU ALA PRO LYS SER SEQRES 13 A 526 ILE VAL THR ALA GLN TYR HIS PHE GLN ASN ASN TYR GLY SEQRES 14 A 526 TYR HIS LEU ASN ALA ALA LYS PHE SER GLN LEU LEU THR SEQRES 15 A 526 GLU HIS CYS THR GLN LYS LEU GLY VAL THR HIS ILE ARG SEQRES 16 A 526 ASP HIS VAL SER GLN ILE ILE ASN ASN GLN HIS GLY ASP SEQRES 17 A 526 ILE GLU LYS LEU ILE THR LYS GLN ASN GLY GLU ILE SER SEQRES 18 A 526 GLY GLN LEU PHE ILE ASP CYS THR GLY ALA LYS SER LEU SEQRES 19 A 526 LEU LEU GLY GLU HIS LEU GLN VAL PRO PHE LEU SER GLN SEQRES 20 A 526 LYS SER VAL LEU PHE ASN ASP ARG ALA LEU ALA ILE GLN SEQRES 21 A 526 VAL PRO TYR SER ASP ALA ASN SER PRO ILE ALA SER CYS SEQRES 22 A 526 THR HIS SER THR ALA GLN PRO ASN GLY TRP ILE TRP ASP SEQRES 23 A 526 ILE GLY LEU PRO THR ARG LYS GLY VAL GLY TYR VAL TYR SEQRES 24 A 526 SER SER SER HIS THR ASN ASP ILE ASP ALA GLN LYS THR SEQRES 25 A 526 LEU PHE ASN TYR LEU GLY VAL ASP GLY ALA ALA ALA ASP SEQRES 26 A 526 LYS LEU GLU PRO ARG GLN LEU ALA ILE ASN PRO GLY TYR SEQRES 27 A 526 ARG ALA LYS CYS TRP GLN ASN ASN CYS ILE ALA ILE GLY SEQRES 28 A 526 MSE ALA ALA GLY PHE ILE GLU PRO LEU GLU ALA SER ALA SEQRES 29 A 526 LEU ALA LEU ILE GLU TRP THR ALA SER THR LEU ALA GLN SEQRES 30 A 526 GLN LEU PRO PRO ASN ARG MSE VAL MSE ASP THR ILE SER SEQRES 31 A 526 ALA ARG VAL ASN GLU ARG TYR GLN GLN HIS TRP GLN GLN SEQRES 32 A 526 ILE ILE ASP PHE LEU LYS LEU HIS TYR VAL ILE SER GLN SEQRES 33 A 526 ARG GLN GLU ASP ARG TYR TRP ARG ASP HIS ARG GLU SER SEQRES 34 A 526 ASN SER ILE PRO ASP SER LEU GLN ALA MSE LEU GLU LEU SEQRES 35 A 526 TRP ARG TYR GLN THR PRO SER GLN GLN ASP ILE SER TYR SEQRES 36 A 526 LYS GLU ALA LEU PHE PRO ALA ALA SER PHE GLN TYR VAL SEQRES 37 A 526 LEU TYR GLY MSE SER PHE ASN THR GLN LEU PRO THR HIS SEQRES 38 A 526 VAL LYS PRO SER MSE GLN GLN LEU ALA GLN ARG LEU PHE SEQRES 39 A 526 ASN ASP ASN GLN GLN ARG THR GLN ALA LEU SER LYS ASN SEQRES 40 A 526 LEU PRO THR ASN ARG GLU LEU LEU ASP LYS VAL ALA GLN SEQRES 41 A 526 TYR GLY PHE PRO LYS LEU SEQRES 1 B 526 GLY MSE MSE GLN LYS PRO ILE THR GLU ILE ILE ILE VAL SEQRES 2 B 526 GLY GLY GLY THR ALA GLY TRP ILE THR ALA GLY LEU LEU SEQRES 3 B 526 ALA ALA GLU HIS ASN VAL ASP LYS GLY VAL LEU ALA HIS SEQRES 4 B 526 SER PRO LYS LEU ASN ILE THR LEU ILE GLU SER PRO ASP SEQRES 5 B 526 VAL ALA THR ILE GLY VAL GLY GLU GLY THR TRP PRO SER SEQRES 6 B 526 MSE ARG SER THR LEU SER LYS ILE GLY ILE ASP GLU ASN SEQRES 7 B 526 ASP PHE ILE ARG GLN CYS ASP ALA SER PHE LYS GLN GLY SEQRES 8 B 526 SER ARG PHE ILE ASN TRP CYS LYS ASP PRO GLN SER ASN SEQRES 9 B 526 VAL ALA ASP SER TYR LEU HIS PRO PHE SER LEU PRO HIS SEQRES 10 B 526 GLY HIS GLN GLU LEU ASP LEU CYS PRO TYR TRP LEU PRO SEQRES 11 B 526 HIS ALA GLU GLN VAL SER PHE ALA GLU ALA VAL CYS SER SEQRES 12 B 526 GLN GLN VAL LEU THR GLN LEU GLY LEU ALA PRO LYS SER SEQRES 13 B 526 ILE VAL THR ALA GLN TYR HIS PHE GLN ASN ASN TYR GLY SEQRES 14 B 526 TYR HIS LEU ASN ALA ALA LYS PHE SER GLN LEU LEU THR SEQRES 15 B 526 GLU HIS CYS THR GLN LYS LEU GLY VAL THR HIS ILE ARG SEQRES 16 B 526 ASP HIS VAL SER GLN ILE ILE ASN ASN GLN HIS GLY ASP SEQRES 17 B 526 ILE GLU LYS LEU ILE THR LYS GLN ASN GLY GLU ILE SER SEQRES 18 B 526 GLY GLN LEU PHE ILE ASP CYS THR GLY ALA LYS SER LEU SEQRES 19 B 526 LEU LEU GLY GLU HIS LEU GLN VAL PRO PHE LEU SER GLN SEQRES 20 B 526 LYS SER VAL LEU PHE ASN ASP ARG ALA LEU ALA ILE GLN SEQRES 21 B 526 VAL PRO TYR SER ASP ALA ASN SER PRO ILE ALA SER CYS SEQRES 22 B 526 THR HIS SER THR ALA GLN PRO ASN GLY TRP ILE TRP ASP SEQRES 23 B 526 ILE GLY LEU PRO THR ARG LYS GLY VAL GLY TYR VAL TYR SEQRES 24 B 526 SER SER SER HIS THR ASN ASP ILE ASP ALA GLN LYS THR SEQRES 25 B 526 LEU PHE ASN TYR LEU GLY VAL ASP GLY ALA ALA ALA ASP SEQRES 26 B 526 LYS LEU GLU PRO ARG GLN LEU ALA ILE ASN PRO GLY TYR SEQRES 27 B 526 ARG ALA LYS CYS TRP GLN ASN ASN CYS ILE ALA ILE GLY SEQRES 28 B 526 MSE ALA ALA GLY PHE ILE GLU PRO LEU GLU ALA SER ALA SEQRES 29 B 526 LEU ALA LEU ILE GLU TRP THR ALA SER THR LEU ALA GLN SEQRES 30 B 526 GLN LEU PRO PRO ASN ARG MSE VAL MSE ASP THR ILE SER SEQRES 31 B 526 ALA ARG VAL ASN GLU ARG TYR GLN GLN HIS TRP GLN GLN SEQRES 32 B 526 ILE ILE ASP PHE LEU LYS LEU HIS TYR VAL ILE SER GLN SEQRES 33 B 526 ARG GLN GLU ASP ARG TYR TRP ARG ASP HIS ARG GLU SER SEQRES 34 B 526 ASN SER ILE PRO ASP SER LEU GLN ALA MSE LEU GLU LEU SEQRES 35 B 526 TRP ARG TYR GLN THR PRO SER GLN GLN ASP ILE SER TYR SEQRES 36 B 526 LYS GLU ALA LEU PHE PRO ALA ALA SER PHE GLN TYR VAL SEQRES 37 B 526 LEU TYR GLY MSE SER PHE ASN THR GLN LEU PRO THR HIS SEQRES 38 B 526 VAL LYS PRO SER MSE GLN GLN LEU ALA GLN ARG LEU PHE SEQRES 39 B 526 ASN ASP ASN GLN GLN ARG THR GLN ALA LEU SER LYS ASN SEQRES 40 B 526 LEU PRO THR ASN ARG GLU LEU LEU ASP LYS VAL ALA GLN SEQRES 41 B 526 TYR GLY PHE PRO LYS LEU MODRES 2PYX MSE A 1 MET SELENOMETHIONINE MODRES 2PYX MSE A 2 MET SELENOMETHIONINE MODRES 2PYX MSE A 65 MET SELENOMETHIONINE MODRES 2PYX MSE A 351 MET SELENOMETHIONINE MODRES 2PYX MSE A 383 MET SELENOMETHIONINE MODRES 2PYX MSE A 385 MET SELENOMETHIONINE MODRES 2PYX MSE A 438 MET SELENOMETHIONINE MODRES 2PYX MSE A 471 MET SELENOMETHIONINE MODRES 2PYX MSE A 485 MET SELENOMETHIONINE MODRES 2PYX MSE B 1 MET SELENOMETHIONINE MODRES 2PYX MSE B 2 MET SELENOMETHIONINE MODRES 2PYX MSE B 65 MET SELENOMETHIONINE MODRES 2PYX MSE B 351 MET SELENOMETHIONINE MODRES 2PYX MSE B 383 MET SELENOMETHIONINE MODRES 2PYX MSE B 385 MET SELENOMETHIONINE MODRES 2PYX MSE B 438 MET SELENOMETHIONINE MODRES 2PYX MSE B 471 MET SELENOMETHIONINE MODRES 2PYX MSE B 485 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 2 8 HET MSE A 65 8 HET MSE A 351 13 HET MSE A 383 13 HET MSE A 385 8 HET MSE A 438 8 HET MSE A 471 8 HET MSE A 485 13 HET MSE B 1 8 HET MSE B 2 8 HET MSE B 65 8 HET MSE B 351 13 HET MSE B 383 18 HET MSE B 385 8 HET MSE B 438 13 HET MSE B 471 8 HET MSE B 485 13 HET CL A 526 1 HET TLA A 527 10 HET TLA A 528 10 HET PG4 A 529 13 HET TLA B 526 10 HET TLA B 527 10 HET PG4 B 528 13 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM TLA L(+)-TARTARIC ACID HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 3 CL CL 1- FORMUL 4 TLA 4(C4 H6 O6) FORMUL 6 PG4 2(C8 H18 O5) FORMUL 10 HOH *1587(H2 O) HELIX 1 1 GLY A 0 LYS A 4 5 5 HELIX 2 2 GLY A 14 ASN A 30 1 17 HELIX 3 3 PRO A 63 GLY A 73 1 11 HELIX 4 4 ASP A 75 CYS A 83 1 9 HELIX 5 5 LEU A 123 LEU A 128 1 6 HELIX 6 6 PRO A 129 ALA A 131 5 3 HELIX 7 7 SER A 135 CYS A 141 1 7 HELIX 8 8 SER A 142 LEU A 149 1 8 HELIX 9 9 ASN A 172 LYS A 187 1 16 HELIX 10 10 THR A 228 SER A 232 5 5 HELIX 11 11 GLN A 246 PHE A 251 1 6 HELIX 12 12 ASN A 304 GLY A 317 1 14 HELIX 13 13 ASP A 319 LEU A 326 1 8 HELIX 14 14 GLY A 350 ALA A 352 5 3 HELIX 15 15 ALA A 361 GLN A 377 1 17 HELIX 16 16 ASN A 381 ILE A 413 1 33 HELIX 17 17 ASP A 419 HIS A 425 1 7 HELIX 18 18 ARG A 426 ILE A 431 5 6 HELIX 19 19 PRO A 432 ARG A 443 1 12 HELIX 20 20 SER A 448 ILE A 452 5 5 HELIX 21 21 PRO A 460 MSE A 471 1 12 HELIX 22 22 LYS A 482 LEU A 507 1 26 HELIX 23 23 THR A 509 TYR A 520 1 12 HELIX 24 24 GLY B 0 LYS B 4 5 5 HELIX 25 25 GLY B 14 ASN B 30 1 17 HELIX 26 26 PRO B 63 GLY B 73 1 11 HELIX 27 27 ASP B 75 CYS B 83 1 9 HELIX 28 28 LEU B 123 LEU B 128 1 6 HELIX 29 29 PRO B 129 ALA B 131 5 3 HELIX 30 30 SER B 135 CYS B 141 1 7 HELIX 31 31 SER B 142 LEU B 149 1 8 HELIX 32 32 ASN B 172 LYS B 187 1 16 HELIX 33 33 THR B 228 SER B 232 5 5 HELIX 34 34 GLN B 246 PHE B 251 1 6 HELIX 35 35 ASN B 304 GLY B 317 1 14 HELIX 36 36 ASP B 319 LEU B 326 1 8 HELIX 37 37 ALA B 361 GLN B 377 1 17 HELIX 38 38 VAL B 384 ILE B 413 1 30 HELIX 39 39 ASP B 419 ARG B 426 1 8 HELIX 40 40 GLU B 427 ILE B 431 5 5 HELIX 41 41 PRO B 432 ARG B 443 1 12 HELIX 42 42 SER B 448 ILE B 452 5 5 HELIX 43 43 PRO B 460 MSE B 471 1 12 HELIX 44 44 LYS B 482 ASN B 506 1 25 HELIX 45 45 THR B 509 TYR B 520 1 12 SHEET 1 A 6 THR A 191 ARG A 194 0 SHEET 2 A 6 ASN A 43 GLU A 48 1 N LEU A 46 O THR A 191 SHEET 3 A 6 GLU A 8 VAL A 12 1 N ILE A 11 O THR A 45 SHEET 4 A 6 LEU A 223 ASP A 226 1 O ILE A 225 N VAL A 12 SHEET 5 A 6 CYS A 346 ALA A 348 1 O ILE A 347 N ASP A 226 SHEET 6 A 6 TRP A 342 GLN A 343 -1 N GLN A 343 O CYS A 346 SHEET 1 B 2 VAL A 31 ASP A 32 0 SHEET 2 B 2 VAL A 35 LEU A 36 -1 O VAL A 35 N ASP A 32 SHEET 1 C 3 GLU A 59 GLY A 60 0 SHEET 2 C 3 GLY A 168 LEU A 171 -1 O LEU A 171 N GLU A 59 SHEET 3 C 3 SER A 86 LYS A 88 -1 N LYS A 88 O GLY A 168 SHEET 1 D 7 SER A 107 PRO A 111 0 SHEET 2 D 7 GLY A 90 ILE A 94 -1 N SER A 91 O HIS A 110 SHEET 3 D 7 THR A 273 GLN A 278 1 O THR A 273 N ARG A 92 SHEET 4 D 7 GLY A 281 GLY A 287 -1 O GLY A 281 N GLN A 278 SHEET 5 D 7 ARG A 291 TYR A 298 -1 O VAL A 297 N TRP A 282 SHEET 6 D 7 ARG A 254 PRO A 261 -1 N VAL A 260 O LYS A 292 SHEET 7 D 7 ARG A 329 ALA A 332 -1 O ARG A 329 N ALA A 257 SHEET 1 E 3 VAL A 197 ASN A 202 0 SHEET 2 E 3 ILE A 208 THR A 213 -1 O GLU A 209 N ILE A 201 SHEET 3 E 3 GLU A 218 SER A 220 -1 O ILE A 219 N LEU A 211 SHEET 1 F 3 PHE A 243 SER A 245 0 SHEET 2 F 3 GLY A 336 ARG A 338 -1 O TYR A 337 N LEU A 244 SHEET 3 F 3 GLY A 354 PHE A 355 -1 O PHE A 355 N GLY A 336 SHEET 1 G 6 THR B 191 ARG B 194 0 SHEET 2 G 6 ASN B 43 GLU B 48 1 N LEU B 46 O THR B 191 SHEET 3 G 6 GLU B 8 VAL B 12 1 N ILE B 11 O THR B 45 SHEET 4 G 6 LEU B 223 ASP B 226 1 O ILE B 225 N VAL B 12 SHEET 5 G 6 CYS B 346 ALA B 348 1 O ILE B 347 N ASP B 226 SHEET 6 G 6 TRP B 342 GLN B 343 -1 N GLN B 343 O CYS B 346 SHEET 1 H 2 VAL B 31 ASP B 32 0 SHEET 2 H 2 VAL B 35 LEU B 36 -1 O VAL B 35 N ASP B 32 SHEET 1 I 3 GLU B 59 GLY B 60 0 SHEET 2 I 3 GLY B 168 LEU B 171 -1 O LEU B 171 N GLU B 59 SHEET 3 I 3 SER B 86 LYS B 88 -1 N LYS B 88 O GLY B 168 SHEET 1 J 7 SER B 107 PRO B 111 0 SHEET 2 J 7 GLY B 90 ILE B 94 -1 N SER B 91 O HIS B 110 SHEET 3 J 7 THR B 273 GLN B 278 1 O THR B 273 N ARG B 92 SHEET 4 J 7 GLY B 281 GLY B 287 -1 O GLY B 281 N GLN B 278 SHEET 5 J 7 ARG B 291 TYR B 298 -1 O VAL B 297 N TRP B 282 SHEET 6 J 7 ARG B 254 PRO B 261 -1 N VAL B 260 O LYS B 292 SHEET 7 J 7 ARG B 329 ALA B 332 -1 O LEU B 331 N ALA B 255 SHEET 1 K 3 VAL B 197 ASN B 202 0 SHEET 2 K 3 ILE B 208 THR B 213 -1 O GLU B 209 N ILE B 201 SHEET 3 K 3 GLU B 218 SER B 220 -1 O ILE B 219 N LEU B 211 SHEET 1 L 3 PHE B 243 SER B 245 0 SHEET 2 L 3 GLY B 336 ARG B 338 -1 O TYR B 337 N LEU B 244 SHEET 3 L 3 GLY B 354 PHE B 355 -1 O PHE B 355 N GLY B 336 LINK C GLY A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N MSE A 2 1555 1555 1.32 LINK C MSE A 2 N GLN A 3 1555 1555 1.34 LINK C SER A 64 N MSE A 65 1555 1555 1.34 LINK C MSE A 65 N ARG A 66 1555 1555 1.33 LINK C GLY A 350 N MSE A 351 1555 1555 1.33 LINK C MSE A 351 N ALA A 352 1555 1555 1.34 LINK C ARG A 382 N MSE A 383 1555 1555 1.33 LINK C MSE A 383 N VAL A 384 1555 1555 1.33 LINK C VAL A 384 N MSE A 385 1555 1555 1.34 LINK C MSE A 385 N ASP A 386 1555 1555 1.33 LINK C ALA A 437 N MSE A 438 1555 1555 1.33 LINK C MSE A 438 N LEU A 439 1555 1555 1.32 LINK C GLY A 470 N MSE A 471 1555 1555 1.32 LINK C MSE A 471 N SER A 472 1555 1555 1.34 LINK C SER A 484 N MSE A 485 1555 1555 1.33 LINK C MSE A 485 N GLN A 486 1555 1555 1.32 LINK C GLY B 0 N MSE B 1 1555 1555 1.33 LINK C MSE B 1 N MSE B 2 1555 1555 1.32 LINK C MSE B 2 N GLN B 3 1555 1555 1.34 LINK C SER B 64 N MSE B 65 1555 1555 1.34 LINK C MSE B 65 N ARG B 66 1555 1555 1.34 LINK C GLY B 350 N MSE B 351 1555 1555 1.33 LINK C MSE B 351 N ALA B 352 1555 1555 1.33 LINK C ARG B 382 N MSE B 383 1555 1555 1.33 LINK C MSE B 383 N VAL B 384 1555 1555 1.33 LINK C VAL B 384 N MSE B 385 1555 1555 1.34 LINK C MSE B 385 N ASP B 386 1555 1555 1.33 LINK C ALA B 437 N MSE B 438 1555 1555 1.33 LINK C MSE B 438 N LEU B 439 1555 1555 1.32 LINK C GLY B 470 N MSE B 471 1555 1555 1.32 LINK C MSE B 471 N SER B 472 1555 1555 1.33 LINK C SER B 484 N MSE B 485 1555 1555 1.33 LINK C MSE B 485 N GLN B 486 1555 1555 1.34 SITE 1 AC1 3 GLY A 58 ALA A 173 HOH A 730 SITE 1 AC2 14 GLY A 15 THR A 16 ALA A 17 GLY A 229 SITE 2 AC2 14 GLY A 350 MSE A 351 HOH A 602 HOH A 610 SITE 3 AC2 14 HOH A 644 HOH A 829 HOH A 931 HOH A 987 SITE 4 AC2 14 HOH A 995 HOH A1301 SITE 1 AC3 14 LYS A 247 ASP A 253 ARG A 254 ILE A 333 SITE 2 AC3 14 ASN A 334 HOH A 695 LYS B 247 ASP B 253 SITE 3 AC3 14 ARG B 254 ILE B 333 ASN B 334 HOH B 719 SITE 4 AC3 14 HOH B1263 HOH B1283 SITE 1 AC4 15 GLY B 15 THR B 16 ALA B 17 GLY B 229 SITE 2 AC4 15 GLY B 350 MSE B 351 HOH B 611 HOH B 659 SITE 3 AC4 15 HOH B 739 HOH B 746 HOH B 955 HOH B1055 SITE 4 AC4 15 HOH B1133 HOH B1154 HOH B1332 SITE 1 AC5 6 LYS A 516 GLN A 519 HOH A1023 ARG B 81 SITE 2 AC5 6 TYR B 520 HOH B 832 SITE 1 AC6 11 LEU A 24 GLU A 28 SER A 67 THR A 68 SITE 2 AC6 11 LYS A 71 GLU A 368 SER A 372 ALA A 375 SITE 3 AC6 11 GLN A 376 HOH A 553 HOH A 999 SITE 1 AC7 9 LEU B 24 GLU B 28 SER B 67 THR B 68 SITE 2 AC7 9 LYS B 71 GLU B 368 SER B 372 GLN B 376 SITE 3 AC7 9 HOH B 568 CRYST1 97.545 109.613 120.036 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010252 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009123 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008331 0.00000 MASTER 381 0 25 45 48 0 21 6 0 0 0 82 END